Concepedia

Howard D. Uderman

HD

16

Publications

455

Citations

12

H-Index

1982

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Vanderbilt University

Vanderbilt University Medical Center

University Medical Center of Princeton

Howard D. Uderman is an author at Bristol-Myers Squibb (United States) specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

1982–2009

16

Publications

16

Pharmacokinetics and Pharmacodynamics of Irbesartan in Healthy Subjects

Maria Rosaria Marino, Kathleen M. Langenbacher, Neville F. Ford et al. · The Journal of Clinical Pharmacology · 1998 · 70 citations

A Dose‐Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Gatifloxacin in Healthy Adult Men

Diptee A. Gajjar, Frank LaCreta, Howard D. Uderman et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2000 · 61 citations

Plasma Distribution, Disappearance Half-Time, Metabolic Clearance Rate, and Degradation of Synthetic Ovine Corticotropin-Releasing Factor in Man*

Wendell E. Nicholson, G. Stephen DeCherney, Richard V. Jackson et al. · The Journal of Clinical Endocrinology & Metabolism · 1983 · 50 citations

Pharmacokinetics and Tolerability of Buspirone during Oral Administration to Children and Adolescents with Anxiety Disorder and Normal Healthy Adults

Daniel E. Salazar, Edyta J. Frackiewicz, Randy Dockens et al. · The Journal of Clinical Pharmacology · 2001 · 48 citations

Attenuation of the development of hypertension in spontaneously hypertensive rats by the thromboxane synthetase inhibitor, 4′-(imidazol-1-yl) acetophenone

Howard D. Uderman, Robert J. Workman, Edwin K. Jackson · Prostaglandins · 1982 · 35 citations

, , +10

Rows per page

1–5 of 16